Clinical trials
Phase 2 Leukemia, Myeloid, Acute trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cooperative Study Group A for Hematology | 3 |
| Shanghai Jiao Tong University School of Medicine | 3 |
| The First Affiliated Hospital of Soochow University | 3 |
| The University of Hong Kong | 3 |
| Colorado Blood Cancer Institute | 2 |
| Ge Zheng | 2 |
| Groupe Francophone des Myelodysplasies | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| Sun Yat-sen University | 2 |
| Tarapeutics Science Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 73 |
| Myelodysplastic Syndromes | 16 |
| Leukemia | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Recurrence | 10 |
| Lymphoma | 7 |
| Multiple Myeloma | 7 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Follicular | 5 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.